Paper30085331
Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway.
Tang Z and 5 others. Mol Med Rep, 2018. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway. Papers, record 30085331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30085331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apolipoproteins E | Major topic |
| Endothelium, Vascular | Major topic |
| Hypoglycemic Agents | Major topic |
| Peptides | Major topic |
| Venoms | Major topic |
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Animals | |
| Arteries | |
| Biopterins | |
| Exenatide | |
| GTP Cyclohydrolase | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred Strains | |
| Nitric Oxide | |
| Nitric Oxide Synthase Type III | |
| Vasodilation |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14707037 | Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. | Arterioscler Thromb Vasc Biol | 2004 | https://conductscience.org/library/papers/14707037 | PubMed |
| 2 | 26322175 | Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. | World J Biol Chem | 2015 | https://conductscience.org/library/papers/26322175 | PubMed |
| 3 | 16946131 | Tetrahydrobiopterin and cardiovascular disease. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16946131 | PubMed |
| 4 | 18708025 | GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP. | Arch Biochem Biophys | 2008 | https://conductscience.org/library/papers/18708025 | PubMed |
| 5 | 16179591 | Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. | Circ Res | 2005 | https://conductscience.org/library/papers/16179591 | PubMed |
| 6 | 17272747 | Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/17272747 | PubMed |
| 7 | 11397713 | Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11397713 | PubMed |
| 8 | 17463333 | A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/17463333 | PubMed |
| 9 | 10469573 | The Akt kinase signals directly to endothelial nitric oxide synthase. | Curr Biol | 1999 | https://conductscience.org/library/papers/10469573 | PubMed |
| 10 | 7356152 | Analysis of reduced forms of biopterin in biological tissues and fluids. | Anal Biochem | 1980 | https://conductscience.org/library/papers/7356152 | PubMed |
| 11 | 12588755 | Endothelial dysfunction: a marker of atherosclerotic risk. | Arterioscler Thromb Vasc Biol | 2003 | https://conductscience.org/library/papers/12588755 | PubMed |
| 12 | 26338040 | Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study. | Cardiovasc Diabetol | 2015 | https://conductscience.org/library/papers/26338040 | PubMed |
| 13 | 26499181 | Vascular nitric oxide: Beyond eNOS. | J Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26499181 | PubMed |
| 14 | 18427132 | Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. | Circulation | 2008 | https://conductscience.org/library/papers/18427132 | PubMed |
| 15 | 6508212 | Performance of three enzymic methods for filter paper glucose determination. | Ann Clin Biochem | 1984 | https://conductscience.org/library/papers/6508212 | PubMed |
| 16 | 18268143 | Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. | Circulation | 2008 | https://conductscience.org/library/papers/18268143 | PubMed |
| 17 | 12176133 | GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation. | Cardiovasc Res | 2002 | https://conductscience.org/library/papers/12176133 | PubMed |
| 18 | 21167014 | The cardiovascular effects of GLP-1 receptor agonists. | Cardiovasc Ther | 2012 | https://conductscience.org/library/papers/21167014 | PubMed |
| 19 | 23709595 | Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes. | Am J Physiol Heart Circ Physiol | 2013 | https://conductscience.org/library/papers/23709595 | PubMed |
| 20 | 26316699 | Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26316699 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38720777 | Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38720777 | PubMed |
| 36311291 | Characterization of Ferroptosis-Related Molecular Subtypes with Immune Infiltrations in Neuropathic Pain. | J Pain Res | 2022 | https://conductscience.org/library/papers/36311291 | PubMed |
| 36140374 | Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140374 | PubMed |
| 35947249 | SGLT2 Inhibitors: New Hope for the Treatment of Acute Myocardial Infarction? | Am J Cardiovasc Drugs | 2022 | https://conductscience.org/library/papers/35947249 | PubMed |
| 32782412 | Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. | Sci Rep | 2020 | https://conductscience.org/library/papers/32782412 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| DPP4 | 1803 | PubTator's text mining | https://conductscience.org/library/genes/1803 | NCBI Gene |
| GCH1 | 2643 | PubTator's text mining | https://conductscience.org/library/genes/2643 | NCBI Gene |
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
| NOS3 | 4846 | PubTator's text mining | https://conductscience.org/library/genes/4846 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30085331
GET https://conductscience.org/api/papers/v1/30085331/references?page=2